Acousia Therapeutics' Series B Round

Acousia Therapeutics raised a round of funding on May 14, 2018.

Acousia Therapeutics is a biotech company that experiments with small molecules for treatment of hearing loss. Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach wil…

Articles about Acousia Therapeutics' Series B Round: